✦ LIBER ✦

Dose and duration-dependence of ganciclovir treatment against murine cytomegalovirus infection in severe combined immunodeficient mice

✍ Scribed by Jianmin Duan; William Paris; Philip Kibler; Christiane Bousquet; Michel Liuzzi; Michael G. Cordingley

Book ID: 114145173
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 139 KB
Volume: 39
Category: Article
ISSN: 0166-3542
DOI: 10.1016/s0166-3542(98)00038-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose- and treatment duration-dependence

Dose- and treatment duration-dependence of ganciclovir against murine cytomegalovirus infection in severe combined immunodeficient mice—experimental and clinical implications

✍ J. Duan; W. Paris; P. Kibler; C. Bousquet; M. Liuzzi; M.G. Cordingley 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Efficacy of (S)-1-(3-hydroxy-2-phosphony

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice

✍ Johan Neyts; Jan Balzarini; Lieve Naesens; Erik de Clercq 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

## Abstract Mice with severe combined immunodeficiency (SCID) inoculated intraperitoneally with murine cytornegalovirus (MCMV) develop a wasting syndrome at 3–4 days and die at 6–9 days after the infection. 9‐(1,3‐Dihydroxy‐2‐propoxyrnethyl)guanine (DHPG, ganciclovir) and (__S__)‐1‐(3‐hydroxy‐2‐pho

Protection against murine cytomegaloviru

Protection against murine cytomegalovirus infection in aged mice and mice with severe combined immunodeficiency disease with the biological response modifiers polyribosinic-polycytidylic acid stabilized with l-lysine and carboxymethylcellulose, maleic anhydride divinyl ether and colony stimulating factor 1

✍ Steven C. Kunder; Linxian Wu; Page S. Morahan 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 707 KB

Efficacy of HPMPC and DHPG in the treatm

Efficacy of HPMPC and DHPG in the treatment of murine cytomegalovirus infection in severe combined immune deficiency (SCID) mice : J. Neyts, J. Balzarini, L. Naesens and E. De Clercq, Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B- 3000 Leuven, Belgium

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 74 KB

107 Treatment of murine cytomegalovirus

107 Treatment of murine cytomegalovirus (MCMV) infections in cell culture and in immunocompromised mice using antibodies to MCMV alone and in combination with ganciclovir (GCV) or (S)-1-(3-hydroxy-2-phosphonylmethoxypropy1)cytosine (HPMPC): D.F. Smee, S.T. Sugiyama, R.W. Sidwell, and B.B. Barnett. Institute for Antiviral Research, Utah State University, Logan, Utah USA

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 78 KB